Taros Chemicals is participating in a new research venture, I3-STM, to develop an immunotherapeutic approach against triple-negative breast cancer (TNBC). This initiative will take place over three years and is funded by the European Union and the state North Rhine-Westphalia…
For the second consecutive time, nineteen external early career researchers were invited to participate, originating from eight countries all over Europe. One of them, the Italian Dr Claudia de Fusco, University of Cambridge, explained “My professor encouraged me to apply…
More than 80 EU Scientists Attended ELF Early Career Researcher Event Read More »
Tissue engineering is one of the most promising therapeutic approaches in modern medicine in the future and offers the chance of giving new healings to millions of people. Previously established carrier polymers have a high rigidity and do not adapt to the requirements of the cells cultivated on them…
Regenerative medicine: Taros and Uni Koeln want to improve tissue culture Read More »
Just a few months after its inclusion for drug target screening, one of the first compounds synthesised within the European Lead Factory was identified as a ‘drug-like’ hit. The compounds were synthesised by the Public Chemistry Consortium, based on library…
It’s early 2015 and the latest European Lead Factory Newsletter is now out. Take a look and discover interesting news and results of this unique European Drug Discovery initiative…
European Lead Factory Newsletter January 2015 Read More »
Taros YMCS Presentation Prize has been awarded in Portugal The Taros YMCS Presentation Prize will be awarded The Taros YMCS Presentation Prize will be awarded to the best oral presentation at the EFMC Young Medicinal Chemist Symposium (EFMC-YMCS), including lectures by invited prize winners from national young medicinal chemist meetings in Europe and oral communications
Taros YMCS Presentation Prize has been awarded in Portugal Read More »
Purification of target compounds is a critical step during chemical matter generation faced by all synthetic organic chemists. Specifically, medicinal chemists in drug discovery require effective, robust purification of compound libraries…
Agilent & Taros partner for “Automated Purification” Read More »
Taros Chemicals celebrates 15 years It was the 15th jubilee celebration of the company and its 10th anniversary in the pharmaceutical hub of Dortmund’s Bio-Medicine Centre. Besides the official inauguration of an additional 500 square meters of high-tech laboratory space, Taros had many more reasons to celebrate on 28th February, 2014, when they were honoured
Taros Chemicals celebrates 15 years Read More »
Taros’ COO, Alexander Piechot, PhD, stated “OPTIBIOCAT is an exciting venture that involves highly skilled and multidisciplinary partners from 16 organizations in eight EU countries. Taros’ involvement will help to set up…
Taros Chemicals Selected to Partner in OPTIBIOCAT Project Read More »
Taros Chemicals GmbH & Co. KG, “Taros” announced the appointment of Prof. Dr. Herbert Waldmann and Prof. Dr. Axel Kleemann as Scientific Advisors to the Taros Management Board…
Taros announces appointment of two Scientific Advisors Read More »
Content
Contact
Taros Chemicals GmbH & Co. KG
Emil-Figge-Str. 76a
44227 Dortmund
GERMANY
© 2022 Taros Chemicals GmbH & Co. KG. All rights reserved.
